Lien Van Eyck
Pfizer (Belgium)(BE)
Publications by Year
Research Areas
Inflammasome and immune disorders, interferon and immune responses, Systemic Lupus Erythematosus Research, Immunodeficiency and Autoimmune Disorders, SARS-CoV-2 and COVID-19 Research
Most-Cited Works
- → Familial autoinflammation with neutrophilic dermatosis reveals a regulatory mechanism of pyrin activation(2016)306 cited
- → Disease-associated mutations identify a novel region in human STING necessary for the control of type I interferon signaling(2017)199 cited
- → Innovative Randomized Phase I Study and Dosing Regimen Selection to Accelerate and Inform Pivotal COVID‐19 Trial of Nirmatrelvir(2022)153 cited
- → Brief Report: IFIH1 Mutation Causes Systemic Lupus Erythematosus With Selective IgA Deficiency(2015)127 cited
- → Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency(2014)121 cited
- → Genetic and phenotypic spectrum associated with IFIH1 gain‐of‐function(2020)110 cited
- → A novel kindred with inherited STAT2 deficiency and severe viral illness(2017)76 cited
- → Olmsted syndrome: exploration of the immunological phenotype(2013)63 cited
- → Machine learning identifies an immunological pattern associated with multiple juvenile idiopathic arthritis subtypes(2019)51 cited
- → Gain-of-function mutations in signal transducer and activator of transcription 1 (STAT1): Chronic mucocutaneous candidiasis accompanied by enamel defects and delayed dental shedding(2014)48 cited